Coronavirus vaccine tracker: When will the one be ready?
newsbytesapp.com/timeline/scien…
newsbytesapp.com/timeline/scien…
Oxford-AstraZeneca vaccine -
The vaccine developed by Oxford University in collaboration with the pharmaceutical firm AstraZeneca is undergoing phase 2 trials in India and phase 3 trials in other parts of the world
The vaccine developed by Oxford University in collaboration with the pharmaceutical firm AstraZeneca is undergoing phase 2 trials in India and phase 3 trials in other parts of the world
The vaccine candidate—called AZD1222 (formerly ChAdOx1 nCoV-19)—is being manufactured by the Serum Institute of India in India
It is expected to be ready by December 2020 with an estimated price of $4 (Rs. 295)
It is expected to be ready by December 2020 with an estimated price of $4 (Rs. 295)
Moderna vaccine -
United States biotechnology company Moderna's mRNA-1273 vaccine is also undergoing the third phase of clinical trials
The phase 3 trials are expected to be complete by September-end with the vaccine potentially hitting the market by the end of this year
United States biotechnology company Moderna's mRNA-1273 vaccine is also undergoing the third phase of clinical trials
The phase 3 trials are expected to be complete by September-end with the vaccine potentially hitting the market by the end of this year
Moderna has said that its vaccine will likely be priced at $32-$37 (Rs. 2,300-Rs. 2,700)
Sinopharm -
Chinese firm Sinopharm is hoping to roll out its coronavirus vaccine candidate by the end of 2020 as well
Currently, the vaccine candidate is undergoing phase 3 trials
The potential vaccine is expected to be priced at $140 (Rs. 10,300)
newsbytesapp.com/timeline/scien…
Chinese firm Sinopharm is hoping to roll out its coronavirus vaccine candidate by the end of 2020 as well
Currently, the vaccine candidate is undergoing phase 3 trials
The potential vaccine is expected to be priced at $140 (Rs. 10,300)
newsbytesapp.com/timeline/scien…
CanSino Biologics Inc. is also developing a potential COVID-19 vaccine, called Ad5-nCOV, in association with the Beijing Institute of Biotechnology
Phase 3 trials are expected to start in September and the potential vaccine is expected to be launched by the end of the year
Phase 3 trials are expected to start in September and the potential vaccine is expected to be launched by the end of the year
Russia's Sputnik V -
Russia has claimed to have launched the first COVID-19 vaccine called Sputnik V on August 11
The vaccine candidate is being developed by the Gamaleya Research Institute and the Russian Defence Ministry
However, the vaccine is yet to undergo phase 3 trials
Russia has claimed to have launched the first COVID-19 vaccine called Sputnik V on August 11
The vaccine candidate is being developed by the Gamaleya Research Institute and the Russian Defence Ministry
However, the vaccine is yet to undergo phase 3 trials
Sputnik V is expected to be out by September-end
No announcement regarding the price has been made
newsbytesapp.com/timeline/scien…
No announcement regarding the price has been made
newsbytesapp.com/timeline/scien…
